Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 993.64 USD 1.16% Market Closed
Market Cap: 939.4B USD

Intrinsic Value

The intrinsic value of one LLY stock under the Base Case scenario is hidden USD. Compared to the current market price of 993.64 USD, Eli Lilly and Co is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

LLY Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Eli Lilly and Co

Intrinsic Value History
Dive into the past to invest in the future

LLY looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether LLY usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about LLY?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LLY valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Eli Lilly and Co.

Explain Valuation
Compare LLY to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Despite the significant buzz around tirzepatide and other diabetes products, their high development and marketing costs could erode profitability if insurance reimbursement or pricing pressures intensify, particularly in today’s cost-conscious healthcare environment.

Bull Theses

Tirzepatide’s rapid approvals and robust clinical outcomes in diabetes and obesity treatments position Eli Lilly to capture valuable market share in a high-growth therapeutic area, protecting long-term revenue streams.

Show More Less
How do you feel about LLY?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eli Lilly and Co

Current Assets 62.1B
Cash & Short-Term Investments 9.9B
Receivables 19.5B
Other Current Assets 32.7B
Non-Current Assets 52.9B
Long-Term Investments 2.8B
PP&E 22.3B
Intangibles 12.3B
Other Non-Current Assets 15.4B
Current Liabilities 40.1B
Accounts Payable 4.3B
Accrued Liabilities 19.6B
Other Current Liabilities 16.3B
Non-Current Liabilities 51B
Long-Term Debt 40.9B
Other Non-Current Liabilities 10.1B
Efficiency

Free Cash Flow Analysis
Eli Lilly and Co

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Eli Lilly and Co

Revenue
59.4B USD
Cost of Revenue
-10.1B USD
Gross Profit
49.3B USD
Operating Expenses
-22.9B USD
Operating Income
26.4B USD
Other Expenses
-8B USD
Net Income
18.4B USD
Fundamental Scores

LLY Profitability Score
Profitability Due Diligence

Eli Lilly and Co's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
Exceptional Operating Margin
ROE is Increasing
hidden
Profitability
Score

Eli Lilly and Co's profitability score is hidden . The higher the profitability score, the more profitable the company is.

LLY Solvency Score
Solvency Due Diligence

Eli Lilly and Co's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Eli Lilly and Co's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LLY Price Targets Summary
Eli Lilly and Co

Wall Street analysts forecast LLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LLY is 1 068.35 USD with a low forecast of 713.1 USD and a high forecast of 1 575 USD.

Lowest
Price Target
713.1 USD
28% Downside
Average
Price Target
1 068.35 USD
8% Upside
Highest
Price Target
1 575 USD
59% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LLY is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LLY Insider Trading
Buy and sell transactions by insiders

LLY News

Other Videos
What is the Intrinsic Value of one LLY stock?

The intrinsic value of one LLY stock under the Base Case scenario is hidden USD.

Is LLY stock undervalued or overvalued?

Compared to the current market price of 993.64 USD, Eli Lilly and Co is hidden .

Back to Top